MSAT Engineer II
Humacyte Inc - North Carolina, Durham, NC, US
Posted Nov 4, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- Not verified
- 401(k) match
- Reported not verified - source URL not recorded; timestamp not recorded
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $116,543 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +9.8% - Much faster than average
Matched to SOC 15-1252 - Software Engineering aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
MSAT Engineer II North Carolina, Durham, NC, US DEPARTMENT: MSAT LOCATION: Durham, NC; Onsite/Not Remote COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Humacyte's initial opportunity, a portfolio of Acellular Tissue Engineered Vessel (ATEVs), is currently approved for use in vascular trauma repair and is in late-stage clinical trials targeting multiple other applications including AV access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass graft, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte's 6mm ATEV for AV access in hemodialysis was the first product candidate to receive the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation and has also received FDA Fast Track designation. Humacyte's 6mm ATEV for urgent arterial repair following extremity vascular trauma also received the RMAT designation. For more information, visit www.Humacyte.com . JOB SUMMARY: The MSAT Engineer II is responsible for providing engineering expertise and technical support for Humacyte's commercial and clinical manufacturing processes. This role serves as a general process engineer for all bioprocessing operations, but specifically this position will focus on manufacturing process support and product lifecycle management activities. With limited supervision, this position will perform support of routine operations, execute engineering studies,
Read the full description at workforcenow.adp.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
MSAT & Packaging Engineer II
Humacyte Inc - North Carolina, Durham, NC, US
Manufacturing Sciences and Technology (MSAT) Process Engineer (3rd Shift)
Orca Bio - Princeton, NJ
Senior Bioprocess Engineer
GSK plc - USA - Pennsylvania - King of Prussia
Engineer II, Conjugation Development and Manufacturing
Vaxcyte Inc - San Carlos, California, United States